
Christopher Dvorak MD
Professor, Pediatrics, UCSF School of Medicine
Join to view full profile
550 16th StSan Francisco, CA 94143
Phone+1 415-476-2188
Dr. Dvorak is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Hematology/Oncology, 2002 - 2005
Stanford Health Care-Sponsored Stanford UniversityResidency, Pediatrics, 1998 - 2001
Vanderbilt University School of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 1999 - 2028
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
Publications & Presentations
PubMed
- Ravulizumab Shows Favorable Survival and Improves Clinical Markers in Children With HSCT-TMA: Results of a Phase 3 Trial.Franco Locatelli, Michelle L Schoettler, David Bueno-Sánchez, Sonali Chaudhury, Jude Fry
American Journal of Hematology. 2026-11-13 - 1 citationsNewborn screening reduces survival disparities in SCID after stem cell transplant: A PIDTC report.Lena E Winestone, Brent R Logan, Xuerong Liu, Olatundun Williams, Elizabeth A Dunn
Journal of Human Immunity. 2026-09-07 - On Hierarchical Composite Endpoints in Pediatric Cancer Supportive Care: Illustrative Examples From Two Multi-Center Phase-III Randomized Clinical Trials.Willem H Collier, Mark Zobeck, Adam J Esbenshade, Christopher C Dvorak, Lillian Sung
Pediatric Blood & Cancer. 2026-09-01
Journal Articles
- Related Peripheral Blood Stem Cell Donors Experience More Severe Symptoms and Less Complete Recovery at 1-Year Compared to Unrelated DonorsParameswaran N Hari, David A Jacobsohn, Joseph P McGuirk, Mary M Horowitz, Walter Longo, Thomas Spitzer, Daniel J Weisdorf, Shahram Mori, David C Delgado, Marcie L Ric..., Haematologica
- Effect of Levofloxacin Prophylaxis on Bacteremia in Children with Acute Leukemia or Undergoing Hematopoietic Stem Cell TransplantationL Charles Bailey, Aditya H Gaur, Michael L Nieder, Michael Green, Christopher C Dvorak, JAMA
- Veno-Occlusive Disease After High-Dose Busulfan–Melphalan in NeuroblastomaGregory Yanik, Morris Kletzel, Stephan Grupp, David Jacobsohn, Christopher C Dvorak, Alix E Seif, Mark Ranalli, Haydar Frangoul, Nature
Abstracts/Posters
- Non-Genotoxic Anti-CD117 Antibody Conditioning Results in Successful Hematopoietic Stem Cell Engraftment in Patients with Severe Combined ImmunodeficiencyChristopher C. Dvorak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Reduced Toxicity Conditioning for Non-Malignant Hematopoietic Cell TransplantsChristopher C. Dvorak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Next Generation Sequence Minimal Residual Disease (NGS-MRD) Predicts Outstanding Event Free Survival (EFS) Regardless of Hematopoietic Cell Transplantation (HCT) Prepa...Christopher C. Dvorak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Incidence and Cost of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome with and without Multi-Organ Dysfunction: Analysis of the Premier Healthcare Database61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Career-Development Lunch Sessions: Pediatric Clinical Malignant Hematology/BMT60th American Society of Hematology Annual Meeting - 12/1/2018
Press Mentions
Transforming Pediatric Care: How UCSF Research Is Changing LivesMarch 20th, 2025- Gene Therapy May Reverse Hurler Syndrome, a Rare and Severe Illness in KidsNovember 18th, 2021
Grant Support
- Primary Immune Deficiency Treatment Consortium (PIDTC): A resource to drive scientific and clinical advances related to the treatment of inborn errors of immunityUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2029
- Primary Immune Deficiency Treatment ConsortiumUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2009–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: